Target intelligence / Profile preview

Cadherin 12 pseudogene 2 (CDH12P2)

Target
CDH12P2
Molecular classification
Pseudogene, Non-coding RNA element
01

Overview

Cadherin 12 pseudogene 2 (CDH12P2) is one of several non-functional genomic elements derived from the parental Cadherin 12 gene, a type II classical cadherin expressed predominantly in the brain and involved in cell-cell adhesion during neuronal development[1][7]. Pseudogenes like CDH12P2 may not encode functional proteins but can regulate gene expression by acting as competitive endogenous RNAs (ceRNAs) or miRNA sponges—modulating processes such as cancer progression and epithelial-to-mesenchymal transition (EMT)[2]. CDH12P2 is located in the 5q13.2 region, potentially influencing genome stability and has been implicated, though not confirmed, in conditions like spinal muscular atrophy (SMA) due to locus effects[2]. There is no evidence for direct drug targeting, therapeutic intervention, or specific safety concerns tied to CDH12P2[5][2].

Other names
C41-CADCDH12PBr-cadherin pseudogeneCadherin 12 (N-cadherin 2) pseudogene 2CDH12P2
02

Mechanism of action

Not applicable. No drugs directly target this pseudogene.

03

Biological functions

Regulation of parental gene (Cadherin 12) expression, possibly through RNA-mediated mechanisms (e.g., acting as a competitive endogenous RNA, miRNA sponge, or regulator of RNA-binding proteins)Potential involvement in genome instability (SMA region association)
04

Disease associations

Possible role in cancer biology, especially epithelial-to-mesenchymal transition (EMT) and maintenance of cancer-initiating cells, suggested for some pseudogenesSpeculative roles in spinal muscular atrophy (SMA) via effects on genome stability (based on locus location and possible destabilization of the 5q13 region)
05

Biomarkers

Pseudogenes are being investigated as biomarkers in oncology due to their altered expression in some cancers; specific biomarker status for CDH12P2 is unconfirmed but suggested as a possibility for future study

Beyond the preview

Go deeper on Cadherin 12 pseudogene 2 (CDH12P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cadherin 12 pseudogene 2 (CDH12P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call